Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target

Abstract Introduction Thioredoxin (Trx) is a secretory protein that acts as an antioxidant, redox regulator, anti-allergic, and anti-inflammatory molecule. It has been used to treat dermatitis and inflammation of the digestive tract. In the lungs, Trx has a significant anti-inflammatory impact. On t...

Full description

Bibliographic Details
Main Authors: Heena Kansal, Vishal Chopra, Kranti Garg, Siddharth Sharma
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Respiratory Research
Subjects:
Online Access:https://doi.org/10.1186/s12931-023-02574-4
_version_ 1797451752104001536
author Heena Kansal
Vishal Chopra
Kranti Garg
Siddharth Sharma
author_facet Heena Kansal
Vishal Chopra
Kranti Garg
Siddharth Sharma
author_sort Heena Kansal
collection DOAJ
description Abstract Introduction Thioredoxin (Trx) is a secretory protein that acts as an antioxidant, redox regulator, anti-allergic, and anti-inflammatory molecule. It has been used to treat dermatitis and inflammation of the digestive tract. In the lungs, Trx has a significant anti-inflammatory impact. On the other hand, Chronic Obstructive Pulmonary Disease (COPD) is one of the significant causes of death in the developed world, with a tremendous individual and socioeconomic impact. Despite new initiatives and endless treatment trials, COPD incidence and death will likely escalate in the coming decades. Areas covered COPD is a chronic inflammatory disease impacting the airways, lung parenchyma, and pulmonary vasculature. Oxidative stress and protease-antiprotease imbalances are thought to be involved in the process. The most popular respiratory inflammatory and allergic disorders therapies are corticosteroids and β-receptor agonists. These medications are helpful but have some drawbacks, such as infection and immunosuppression; thus, addressing Trx signalling treatments may be a viable COPD treatment approach. This review shall cover the pathophysiology of COPD, the pharmacognosy of anti-COPD drugs, including the assets and liabilities of each, and the role and mechanism of Trx in COPD treatment. Expert opinion Limited research has targeted the thioredoxin system as an anti-COPD drug. Spectating the increase in the mortality rates of COPD, this review article would be an interesting one to research.
first_indexed 2024-03-09T14:58:58Z
format Article
id doaj.art-534c8db7103f4f1d9868a7ac4e3688d2
institution Directory Open Access Journal
issn 1465-993X
language English
last_indexed 2024-03-09T14:58:58Z
publishDate 2023-11-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj.art-534c8db7103f4f1d9868a7ac4e3688d22023-11-26T14:02:00ZengBMCRespiratory Research1465-993X2023-11-0124111810.1186/s12931-023-02574-4Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future targetHeena Kansal0Vishal Chopra1Kranti Garg2Siddharth Sharma3Department of Biotechnology, Thapar Institute of Engineering and TechnologyDepartment of Pulmonary Medicine, Government Medical CollegeDepartment of Pulmonary Medicine, Government Medical CollegeDepartment of Biotechnology, Thapar Institute of Engineering and TechnologyAbstract Introduction Thioredoxin (Trx) is a secretory protein that acts as an antioxidant, redox regulator, anti-allergic, and anti-inflammatory molecule. It has been used to treat dermatitis and inflammation of the digestive tract. In the lungs, Trx has a significant anti-inflammatory impact. On the other hand, Chronic Obstructive Pulmonary Disease (COPD) is one of the significant causes of death in the developed world, with a tremendous individual and socioeconomic impact. Despite new initiatives and endless treatment trials, COPD incidence and death will likely escalate in the coming decades. Areas covered COPD is a chronic inflammatory disease impacting the airways, lung parenchyma, and pulmonary vasculature. Oxidative stress and protease-antiprotease imbalances are thought to be involved in the process. The most popular respiratory inflammatory and allergic disorders therapies are corticosteroids and β-receptor agonists. These medications are helpful but have some drawbacks, such as infection and immunosuppression; thus, addressing Trx signalling treatments may be a viable COPD treatment approach. This review shall cover the pathophysiology of COPD, the pharmacognosy of anti-COPD drugs, including the assets and liabilities of each, and the role and mechanism of Trx in COPD treatment. Expert opinion Limited research has targeted the thioredoxin system as an anti-COPD drug. Spectating the increase in the mortality rates of COPD, this review article would be an interesting one to research.https://doi.org/10.1186/s12931-023-02574-4COPDThioredoxinOxidative stressInflammationROS
spellingShingle Heena Kansal
Vishal Chopra
Kranti Garg
Siddharth Sharma
Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target
Respiratory Research
COPD
Thioredoxin
Oxidative stress
Inflammation
ROS
title Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target
title_full Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target
title_fullStr Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target
title_full_unstemmed Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target
title_short Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target
title_sort role of thioredoxin in chronic obstructive pulmonary disease copd a promising future target
topic COPD
Thioredoxin
Oxidative stress
Inflammation
ROS
url https://doi.org/10.1186/s12931-023-02574-4
work_keys_str_mv AT heenakansal roleofthioredoxininchronicobstructivepulmonarydiseasecopdapromisingfuturetarget
AT vishalchopra roleofthioredoxininchronicobstructivepulmonarydiseasecopdapromisingfuturetarget
AT krantigarg roleofthioredoxininchronicobstructivepulmonarydiseasecopdapromisingfuturetarget
AT siddharthsharma roleofthioredoxininchronicobstructivepulmonarydiseasecopdapromisingfuturetarget